Nearly twice as many people taking semaglutide stopped their fatty liver disease without further scarring of the organ, ...

Currently, there is only one U.S. government-approved treatment available for fatty liver disease, Rezdiffra (resmetirom), ...

Researchers say semaglutide may help reverse MASH, a progressive liver condition affecting millions of Americans.

A trial shows that semaglutide stops fat accumulation and liver fibrosis in a disease associated with metabolic dysfunction ...

Semaglutide is the key component of weight loss and diabetes drugs like Ozempic and Wegovy, and an international team of ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that the substance ...

An international study led by the director of Virginia Commonwealth University’s liver institute suggests that ...

A latest study has shown promising results in people suffering from metabolic dysfunction-associated steatohepatitis (MASH), ...

Viking's leading drug candidate could be a blockbuster in the weight loss market, which experts believe could grow to $150 ...